Innoplexus, founded in 2011, leverages Artificial intelligence, machine learning, and blockchain to revolutionize life sciences. With a portfolio of 190+ US/EU patents, it aggregates and analyzes biomedical data to aid drug discovery, optimize clinical trials, and ensure regulatory compliance. By leveraging its ontology, data and AI models, it accelerates drug development and reduces costs. Committed to innovation and collaboration, it empowers Big Pharma and CROs to bring effective treatments to market efficiently and faster. It is headquartered in Eschborn, Germany, with offices in Pune, India, Iselin and San Francisco, USA.